|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Hadassah Medical Organization |
| Information provided by: | Hadassah Medical Organization |
| ClinicalTrials.gov Identifier: | NCT00589407 |
Purpose
Neck pain is a common complaint in the general population affecting 10-15% of the general population. females more than men. Known risk factors are: Trauma, Repetitive lifting of heavy objects at work, driving vibrating vehicles, frequents diving from boards and smoking. No study dealt with the possible role of unilateral loss of vision or hearing as a risk factor for the development of neck pain. Intuitively, one might suspect that unilateral blindness or deafness will lead to a tilted position of the head, in order to cover a better visual/audio field. This position, in time, might lead to the development of neck pain.
Our hypothesis is that patients with unilateral blindness/deafness will suffer from neck pain more frequently than the general population.
| Condition |
|
Neck Pain Unilateral Blindness Unilateral Deafness |
| Genetics Home Reference related topics: | nonsyndromic deafness |
| MedlinePlus related topics: | Hearing Disorders and Deafness Neck Injuries and Disorders |
| Study Type: | Observational |
| Study Design: | Case Control, Cross-Sectional |
| Official Title: | Unilateral Blindness/ Unilateral Deafness-Relation to Neck Pain |
Eligibility
| Ages Eligible for Study: | 18 Months to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
study group: patients with unilateral blindness and unilateral deafness as the control group: patients attending the eye ENT clinics for other reasons as control
Inclusion criteria:
Exclusion criteria:
Contacts and Locations| Contact: Yair Barzilay | 972-2-6776292 | Dbar@hadassah.org.il |
| Israel | |||||
| Hadassah Medical Organization. | Recruiting | ||||
| Jerusalem, Israel | |||||
| Hadassah Medical Organization |
| Principal Investigator: | Yair Barzilay | Hadassah Medical Organization |
More Information
| Responsible Party: | Hadassah Medical Organization ( Dr. Yair Barzilay ) |
| Study ID Numbers: | BARZ-001HMO-CTIL |
| First Received: | December 23, 2007 |
| Last Updated: | December 23, 2007 |
| ClinicalTrials.gov Identifier: | NCT00589407 |
| Health Authority: | Israel: Ministry of Health |
|
|
|